(Q101051357)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

4 references

13 July 2022

22 October 2022

24 October 2022

25 October 2022

Coronavirus biology and replication: implications for SARS-CoV-2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

Hanspeter Stalder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

Volker Thiel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

author name string

Annika Kratzel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

Silvio Steiner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

publication date

28 October 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Microbiology

31 October 2020

1 March 2021

4 references

13 July 2022

22 October 2022

24 October 2022

25 October 2022

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

13 July 2022

22 October 2022

24 October 2022

25 October 2022

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Hosts and Sources of Endemic Human Coronaviruses.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Nidovirales: evolving the largest RNA virus genome

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Coronaviruses post-SARS: update on replication and pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The molecular biology of coronaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Accessory proteins of SARS-CoV and other coronaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A new virus isolated from the human respiratory tract

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural insights into coronavirus entry

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structure, Function, and Evolution of Coronavirus Spike Proteins

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural basis of receptor recognition by SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A new coronavirus associated with human respiratory disease in China

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Cell entry mechanisms of SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Virological assessment of hospitalized patients with COVID-2019

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A potential role for integrins in host cell entry by SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Neuropilin-1 is a host factor for SARS-CoV-2 infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Spike protein, S, of human coronavirus HKU1: role in viral life cycle and application in antibody detection.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Cleavage of a Neuroinvasive Human Respiratory Virus Spike Glycoprotein by Proprotein Convertases Modulates Neurovirulence and Virus Spread within the Central Nervous System

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

LY6E impairs coronavirus fusion and confers immune control of viral disease

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Site-specific glycan analysis of the SARS-CoV-2 spike

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A human monoclonal antibody blocking SARS-CoV-2 infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The coding capacity of SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Translation and processing of mouse hepatitis virus virion RNA in a cell-free system.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Identification and Characterization of a Human Coronavirus 229E Nonstructural Protein 8-Associated RNA 3'-Terminal Adenylyltransferase Activity

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Human coronavirus 229E nonstructural protein 13: characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5'-triphosphatase activities

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structure of Mpro from COVID-19 virus and discovery of its inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Coronaviruses use discontinuous extension for synthesis of subgenome-length negative strands

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Continuous and Discontinuous RNA Synthesis in Coronaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The Architecture of SARS-CoV-2 Transcriptome

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

New insights about the regulation of Nidovirus subgenomic mRNA synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structure of replicating SARS-CoV-2 polymerase

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural basis for RNA replication by the SARS-CoV-2 polymerase

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The intracellular sites of early replication and budding of SARS-coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Molecular interactions in the assembly of coronaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Severe acute respiratory syndrome coronavirus accessory protein 9b is a virion-associated protein

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-I

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Intracellular localization and protein interactions of the gene 1 protein p28 during mouse hepatitis virus replication.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

RNA replication of mouse hepatitis virus takes place at double-membrane vesicles

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Infectious bronchitis virus generates spherules from zippered endoplasmic reticulum membranes

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A molecular pore spans the double membrane of the coronavirus replication organelle

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Competitive fitness in coronaviruses is not correlated with size or number of double-membrane vesicles under reduced-temperature growth conditions.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Extensive coronavirus-induced membrane rearrangements are not a determinant of pathogenicity.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Antiviral Innate Immune Response Interferes with the Formation of Replication-Associated Membrane Structures Induced by a Positive-Strand RNA Virus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

In Situ Tagged nsp15 Reveals Interactions with Coronavirus Replication/Transcription Complex-Associated Proteins.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Integrity of the early secretory pathway promotes, but is not required for, severe acute respiratory syndrome coronavirus RNA synthesis and virus-induced remodeling of endoplasmic reticulum membranes

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Genome-Wide Screen Reveals Valosin-Containing Protein Requirement for Coronavirus Exit from Endosomes.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The trinity of COVID-19: immunity, inflammation and intervention

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Immunology of COVID-19: Current State of the Science

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Disparate temperature-dependent virus – host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The immunology of COVID-19: is immune modulation an option for treatment?

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Viral and host factors related to the clinical outcome of COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Establishment of an African green monkey model for COVID-19

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Virology: SARS virus infection of cats and ferrets

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Infection of bat and human intestinal organoids by SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

An Infectious cDNA Clone of SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Mechanisms and enzymes involved in SARS coronavirus genome expression

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Identification of a new human coronavirus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Middle East respiratory syndrome coronavirus in bats, Saudi Arabia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A Novel Coronavirus from Patients with Pneumonia in China, 2019

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Clinical Characteristics of Coronavirus Disease 2019 in China

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

A Genomic Perspective on the Origin and Emergence of SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

Origin and evolution of pathogenic coronaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41579-020-00468-6

7 January 2021

10.1038/S41579-020-00468-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33116300%20AND%20SRC:MED&resulttype=core&format=json

31 October 2020

1 reference